HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
1326studies shown
Showing 397-408 of 1,326
Drug study icon
CompletedEUCTR 2008-007482-23

A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
Bipolarity, DepressionHistorical research record
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Drug study icon
CompletedEUCTR 2022-000461-41

A Randomized, Double-blind, Multicenter, Parallel-Group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, Bulgaria, Czechia, + 1 other
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2006-003560-62

A Randomized, Double-Blind, Parallel-Group, Comparative Study of Flexible Doses of Paliperidone Palmitate and Flexible Doses of Risperidone Long-Acting Intramuscular Injection in Subjects with Schi...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
SchizophreniaHistorical research record
Countries
France, Austria, Bulgaria, + 6 others
Sponsor
Janssen-Cilag International N.V.
Drug study icon
CompletedEUCTR 2019-002992-33

A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared Wit...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, Belgium, Austria, + 11 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedNCT00447278

A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents

Official study title

A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning Using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactivity Disorder in Treatment-Naïve Children and Adolescents

This study has finished and is no longer accepting participants.

In France
ADHDMedication studyAges 6–16
Countries
France, United Kingdom, Belgium, + 6 others
Sponsor
Eli Lilly and Company
Other study type icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

Official study title

A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI

This study has finished and is no longer accepting participants.

In France
DepressionObservational studyAges 18–74
Countries
France, United States, Canada, + 8 others
Sponsor
Janssen Research & Development, LLC
Behavioral study icon
TerminatedNCT01077791

A Remediation Program of Social Cognition in Schizophrenia

Official study title

Cognitive Remediation of the Ability to Infer Intention of Others in Schizophrenic Patients - A Controlled, Randomized Trial (Phase IIb)

This study ended early.

In France
SchizophreniaBehavioural studyAges 18–57
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Drug study icon
CompletedNCT00300846

Treatment of Aripiprazole for Schizophrenia

Official study title

A Multicenter, Comparative, Randomized, Double-Blind, Placebo Controlled Study on the Effect on Weight of Adjunctive Treatment With Aripiprazole in Patients With Schizophrenia.

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, United Kingdom, Switzerland, + 9 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00261443

Aripiprazole (Abilify) in people with Bipolar Mania

Official study title

Efficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy

This study has finished and is no longer accepting participants.

In France
BipolarityMedication studyAges 18+
Countries
France, United States, Brazil, + 6 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT05550532

Aticaprant 10 Milligrams (mg) for Depression

What is this study about?

This study evaluated the safety and effectiveness of Aticaprant for people with depression.

This study has finished and is no longer accepting participants.

In France
DepressionMedication studyAges 18–74
Countries
France, United States, Canada, + 11 others
Sponsor
Janssen Research & Development, LLC

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.